Wireless monitors like VitalStream™ can help to drive down the cost of chronic disease management and deliver better patient outcomes.

Chronic disease management (CDM) is one of biggest challenges facing global health. Chronic conditions such as heart disease and diabetes are the leading cause of mortality in the developed world by far, and across the world they are projected to account for 69% of deaths by 2030.

Medical practitioners know that even a brief hypotensive event can harm a patient. This is why the ICU employs continuous hemodynamic monitoring to catch the earliest signs of such events and enable prompt intervention.

However, studies have found that post-operative patients returning to the general ward are still at risk of acute hypotensive events leading to cardiac arrest, and a high proportion of such events are not picked up. This highlights the need for continuous hemodynamic monitoring beyond the critical care wards, a need that can be met by wireless hemodynamic monitoring.

MedTech Innovator, the largest accelerator of medical devices in the world, announced that Caretaker Medical have been selected among five finalists out of 1,100 applicants to compete for the title of MedTech Innovator 2021.

“Every year I am more impressed by the caliber of companies that take part in our Accelerator and Showcase programs,” said Paul Grand. “This year’s five finalist companies are developing products that have the ability to really shake up the industry and provide significant value to patients. We are thrilled to be back in-person for our final competition at the conference and we know the live audience will have an extremely tough decision deciding this year’s winner.” Read more about the competition here or learn more about us today.

We are excited to announce the U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform.

Acute hypotensive events (AHE) are among the most severe threats to intraoperative and postoperative patients. Monitoring blood pressure is, therefore, a critical function for patients, not only in the operating room and ICU but also in the postoperative wards.

An AHE is defined as a drop in the mean arterial pressure below 65 mm Hg, lasting five consecutive minutes of more. It can be a sign of a serious problem, such as bleeding, sepsis, adrenal insufficiency, or cardiac issues. Not surprisingly, it is associated with adverse outcomes in critically ill patients, such as stroke, heart attack, and kidney failure.

There are currently around 400 ketamine infusion clinics in the US and rising at a rate of 30-40% per year. Such is the demand for intravenous ketamine treatment for severe depression, anxiety and chronic pain.

Since the opioid epidemic, the use of analgesics and anesthetics to treat the rising cases of depression and anxiety has been closely monitored and patient safety is understandably paramount. Caretaker Medical’s wireless, continuous patient monitoring is helping ketamine clinics to deliver the best possible patient experience, while streamlining their workflow and ensuring adherence to monitoring protocols.

Background

Contract Research Organizations (CROs) like Celerion conduct drug research studies on behalf of pharmaceutical companies, using cohorts of healthy subjects, who are paid for their participation. A study can last for anything from one day to two months, sometimes longer, and during the trial, subjects’ vital signs are monitored.

Caretaker’s Wireless “Beat-by-Beat” Continuous Blood Pressure monitor is highlighted in Springer’s new book, “The Handbook of Cuffless Blood Pressure Monitoring”, with an entire chapter devoted to our patented Pulse Decomposition Analysis technology.  This practical guide for clinicians, researchers, and engineers outlines a history of blood pressure advances and presents groundbreaking state-of-the-art technologies driving the clinical and scientific future of Continuous, Cuff-less, Blood Pressure Monitoring. The collection of luminaries and industry experts that the book’s editors, Sola and Delgado-Gonzalo, have assembled to write this landmark book is unparalleled and we are proud to be leading the wave of innovation that improves patient care and clinical productivity!